Abstract
The risk of cancer in patients with psoriasis has been of special concern owing to the chronic inflammatory nature of the disease, use of immune suppressive treatments and UV therapies, and the increased prevalence of comorbid, well-established risk factors for cancer, such as smoking, all of which may increase the risk of carcinogenesis.1 Indeed, studies2-8 have previously demonstrated that patients with more severe psoriasis are at an increased risk of cancer-related mortality, and psoriasis has been associated with an increased risk of cancer, including lymphoma. However, these studies have generally not controlled for important confounders, and have often failed to examine the rates of specific cancers or the impact of disease severity on cancer risk. Furthermore, there have often been conflicting data on the risk of specific cancers including lymphoma.1,3,4,6,9 Additional studies are necessary to further define the risk of cancer in patients with this disease.

This publication has 34 references indexed in Scilit: